Application YC di Ansa Biotechnologies

Winter 2020Active

Ansa Biotechnologies ha partecipato a Y Combinator nel batch Winter 2020 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Winter 2020
Settore: HealthcareIndustrial Bio
Dimensione team: 72
Stato: Active
Lanciata: 2022

Founder

Dan Lin-ArlowFounder
Sebastian PallukFounder

Cosa fa Ansa Biotechnologies

Ansa Biotechnologies is developing a new way to make DNA that will be faster, cleaner, and more accurate than existing methods. Currently, DNA is manufactured via a chemical method that has remained mostly unchanged for 35 years. Our enzyme-based approach promises to dramatically accelerate innovation in biological research and biotechnology, including therapeutics, diagnostics and biomanufacturing.

Application YC di Ansa Biotechnologies, ricostruita

Domanda per Y Combinator

Ansa Biotechnologies, batch Winter 2020. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Ansa Biotechnologies

Describe what your company does in 50 characters or less.

Next-generation DNA synthesis using enzymes

What is your company going to make? Please describe your product and what it does or will do.

We are building an enzymatic DNA synthesis platform that replaces the chemical methods labs use today. Our product synthesizes DNA faster, with fewer errors and less waste than traditional phosphoramidite chemistry. This allows researchers and biotech companies to develop new therapeutics, diagnostics, and biological products more quickly and cheaply.

Where do you live now, and where would the company be based after YC?

We live and work in Emeryville, CA, and the company is based here. After YC, we plan to remain in Emeryville because of the strong biotech community and lab infrastructure.

Explain your decision regarding location.

Emeryville gives us access to specialized biotech facilities, vendors, and talent we need to develop our enzyme-driven approach. Relocation is not necessary since this area is ideal for industrial biotech startups like ours.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di Ansa Biotechnologies?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Ansa Biotechnologies (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Ansa Biotechnologies si presenterebbe a YC, non il testo che hanno inviato.

A quale batch YC apparteneva Ansa Biotechnologies?

Ansa Biotechnologies apparteneva al batch Winter 2020 di Y Combinator.

Chi ha fondato Ansa Biotechnologies?

Ansa Biotechnologies è stato fondato da Dan Lin-Arlow, Sebastian Palluk.

Cosa fa Ansa Biotechnologies?

Next-generation DNA synthesis using enzymes

Come leggo la ricostruzione completa della application?

Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Ansa Biotechnologies, e di ogni altro batch YC, è in YC Insights.